These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 14713799)

  • 1. Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis.
    Talan DA; Klimberg IW; Nicolle LE; Song J; Kowalsky SF; Church DA
    J Urol; 2004 Feb; 171(2 Pt 1):734-9. PubMed ID: 14713799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis.
    Peterson J; Kaul S; Khashab M; Fisher AC; Kahn JB
    Urology; 2008 Jan; 71(1):17-22. PubMed ID: 18242357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women.
    Henry DC; Bettis RB; Riffer E; Haverstock DC; Kowalsky SF; Manning K; Hamed KA; Church DA
    Clin Ther; 2002 Dec; 24(12):2088-104. PubMed ID: 12581547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women.
    Fourcroy JL; Berner B; Chiang YK; Cramer M; Rowe L; Shore N
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4137-43. PubMed ID: 16189090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis.
    Cox CE; Marbury TC; Pittman WG; Brown GL; Auerbach SM; Fox BC; Yang JY
    Clin Ther; 2002 Feb; 24(2):223-36. PubMed ID: 11911553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciprofloxacin extended release: in the treatment of urinary tract infections and uncomplicated pyelonephritis.
    Waugh J; Keating GM
    Drugs Aging; 2004; 21(1):55-64; discussion 65-6. PubMed ID: 14715044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis.
    Klausner HA; Brown P; Peterson J; Kaul S; Khashab M; Fisher AC; Kahn JB
    Curr Med Res Opin; 2007 Nov; 23(11):2637-45. PubMed ID: 17880755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option.
    Blondeau JM
    Drugs; 2004; 64(6):611-28. PubMed ID: 15018591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis.
    Bach D; van den Berg-Segers A; Hübner A; van Breukelen G; Cesana M; Plétan Y
    J Urol; 1995 Jul; 154(1):19-24. PubMed ID: 7776420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study.
    Klimberg I; Shockey G; Ellison H; Fuller-Jonap F; Colgan R; Song J; Keating K; Cyrus P
    Curr Med Res Opin; 2005 Aug; 21(8):1241-50. PubMed ID: 16083534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.
    Naber KG; Allin DM; Clarysse L; Haworth DA; James IG; Raini C; Schneider H; Wall A; Weitz P; Hopkins G; Ankel-Fuchs D
    Int J Antimicrob Agents; 2004 Jun; 23(6):596-605. PubMed ID: 15194131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A; Naber KG; Bischoff W; Kullmann K
    J Urol; 1997 Oct; 158(4):1494-9. PubMed ID: 9302150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections.
    Naber KG; Bartnicki A; Bischoff W; Hanus M; Milutinovic S; van Belle F; Schönwald S; Weitz P; Ankel-Fuchs D
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S41-53. PubMed ID: 15037328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial.
    Mombelli G; Pezzoli R; Pinoja-Lutz G; Monotti R; Marone C; Franciolli M
    Arch Intern Med; 1999 Jan; 159(1):53-8. PubMed ID: 9892331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
    Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
    Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI).
    Wagenlehner FM; Umeh O; Steenbergen J; Yuan G; Darouiche RO
    Lancet; 2015 May; 385(9981):1949-56. PubMed ID: 25931244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.
    Talan DA; Stamm WE; Hooton TM; Moran GJ; Burke T; Iravani A; Reuning-Scherer J; Church DA
    JAMA; 2000 Mar 22-29; 283(12):1583-90. PubMed ID: 10735395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complicated urinary tract infections treated with extended-release ciprofloxacin with emphasis on Pseudomonas aeruginosa.
    Saltzstein D; Wachs B; Perroncel R; Benson A; Herrington J; Haverstock D; Pertel P
    J Chemother; 2007 Dec; 19(6):694-702. PubMed ID: 18230553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial.
    Sandberg T; Skoog G; Hermansson AB; Kahlmeter G; Kuylenstierna N; Lannergård A; Otto G; Settergren B; Ekman GS
    Lancet; 2012 Aug; 380(9840):484-90. PubMed ID: 22726802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of ciprofloxacin XR 1000 mg once daily versus ciprofloxacin 500 mg twice daily in the treatment of complicated urinary tract infections.
    Mirone V; Fusco F; Taglialatela D; Verze P; Di Vito C; Lotti T; Imbimbo C;
    J Chemother; 2009 Dec; 21(6):651-60. PubMed ID: 20071289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.